Paroxetine (3R,4S)-N-Methyl Paroxol Impurity :
(3R,4S)-N-Methyl Paroxol ; (3R,4S)-NMA ; C13H18FNO ; MW: 223.29; |
Paroxetine (3S,4R)-N-Methyl Paroxol Impurity :
(3S,4R)-N-Methyl Paroxol ; CAS : 105812-81-5 ; C13H18FNO ; MW: 223.29; |
Paroxetine 3-Hydroxy Metabolite :
3-HM Paroxetine ; CAS : 112058-89-6 ; C19H22FNO3 ; MW: 331.38; |
Paroxetine 4-Hydroxy Metabolite:
4-HM Paroxetine ; CAS : 112058-90-9 ; C12H16FNO ; MW: 209.26; |
Paroxetine 4-Hydroxy Piperidine Impurity :
4-(4-Fluorophenyl)-4-hydroxy-1-methyl-piperidine ; C21H24FNO5 ; MW: 389.42; |
Paroxetine Acetate ;
(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine acetate ; C21H24FNO5 ; MW: 389.42 ; |
Paroxetine Anhydrous Impurity B:
Sesamol ; 3,4-Methylenedioxyphenol ; 1,3-Benzodioxol-5-ol ; CAS : 533-31-3 ; C7H6O3 ; MW: 138.12 ; |
Paroxetine Anhydrous Impurity C :
N-Benzyl Paroxetine HCl ; CAS : 105813-14-7 (base) ; C26H27ClFNO3 ; aqMW: 455.95 ; |
Paroxetine Anhydrous Impurity F :
N-Benzyl Desfluoro Paroxetine HCl ; CAS : 105813-39-6 ; C26H28ClNO3 ; MW: 437.96 ; |
Paroxetine Anhydrous Impurity H :
N-Benzyl Paroxol ; CAS : 201855-60-9 ; C19H22FNO ; MW: 299.38 ; |
Paroxetine Anhydrous Impurity I :
Paroxol ; (3S,4R)-4-(4-Fluorophenyl) piperidine-3-methanol ; CAS : 125224-43-3 ; C12H16FNO ; MW: 209.26; |
Paroxetine Anhydrous Impurity J :
(3S,4R)-trans-4-(4-Fluorobiphenyl)-3-[(3,4-methylenedioxy)phenoxy]methylpiperidine ; C25H24FNO3 ; MW: 405.46; |
Paroxetine Impurity A:
Desfluoro Paroxetine ; Paroxetine Anhydrous EP Impurity A ; Paroxetine USP RC B ; CAS : 324024-00-2 ; C19H21NO3 ; MW: 311.37; |
Paroxetine Impurity B :
4-Methoxy Paroxetine HCl ; Paroxetine USP RC A ; C20H24ClNO4 ; MW: 377.86 ; |
Paroxetine Impurity C :
4-Ethoxy Paroxetine Hydrochloride ; C21H26ClNO4 ; MW: 391.89 ; |
Paroxetine Impurity D :
trans-(+)-Paroxetine HCl ; CAS : 130855-30-0 ; C19H21ClFNO3 ; MW: 365.83 ; |
Paroxetine Impurity E :
Paroxetine Anhydrous EP Impurity E ; C19H21ClFNO3 ; MW: 365.83 |
Paroxetine Impurity F:
Paroxetine Dimer ; Methylene-Bis Paroxetine ; CAS : 606968-05-2 ; C39H40F2N2O6 ; MW: 670.74; |
Paroxetine Impurity G :
CAS : 69675-10-1 ; C12H14FN ; MW: 191.24 ; |
Paroxetine Formate:
(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine formate ; C20H22FNO5 ; MW: 375.39; |
Paroxetine HCl Hemihydrate:
Paroxetine hydrochloride hemihydrate ; CAS : 110429-35-1 ; C19H20FNO3 ; Exact Mass: 329.365403; |
Paroxetine Related Compound E :
4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridinehydrochloride ; C12H15CIFN ; MW: 191.21 + 36.5 g/mol ; |
Paroxetine Related Compound F :
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1-methylpiperidine ; C₂₀H₂₂FNO₃ ; Exact Mass: 343.39 g/mol; |
Paroxetine Maleate :
(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine maleate ; CAS : 64006-44-6 ; C23H24FNO7 ; MW: 445.44 ; |